Therapeutic effects of a small molecule agonist of the relaxin receptor ML290 in liver fibrosis
Elena M. Kaftanovskaya(Florida International University), Alexander I. Agoulnik(Florida International University), Xin Hu(Florida International University), Briana Cervantes(Florida International University), Noel Southall(National Institutes of Health), Irina U. Agoulnik(University of South Florida), Brian A. Ho(Florida International University), Samarjit Patnaik(National Center for Advancing Translational Sciences), Bryan Rivas(Baylor College of Medicine), Mahesh Devarasetty(Forest Institute), Juan Marugán(National Institutes of Health), Elena Barnaeva(National Center for Advancing Translational Sciences), Kenneth J. Wilson(National Institutes of Health), Mariluz Soula(Rockefeller University), Xin Xu(National Institutes of Health), Colin E. Bishop(National Oceanography Centre), Courtney Myhr(Florida International University), Marc Ferrer(National Institute of Biomedical Innovation, Health and Nutrition), Thomas Shupe(Forest Institute), Hooi Hooi Ng(Florida International University)
Cited by 35
Related Papers
Rethinking dog domestication by integrating genetics, archeology, and biogeography
|Proceedings of the National Academy of Sciences|2012|534
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390
A transgenic insertion upstream of Sox9 is associated with dominant XX sex reversal in the mouse
|Nature Genetics|2000|351
Caveolin-1 Is Down-Regulated in Human Ovarian Carcinoma and Acts as a Candidate Tumor Suppressor Gene
|American Journal Of Pathology|2001|279
Therapeutic strategies for diffuse midline glioma from high-throughput combination drug screening
|Science Translational Medicine|2019|259